product summary
Loading...
company name :
Bio X Cell
product type :
antibody
product name :
InVivoPlus anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-β
catalog :
BP0057-5MG
quantity :
5 mg
price :
1,700.00 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
13F3
reactivity :
human, mouse, rat, dogs, bovine
application :
western blot, flow cytometry, blocking or activating experiments
more info or order :
citations: 20
Published Application/Species/Sample/DilutionReference
  • blocking or activating experiments; mouse; loading ...; fig 1l
Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  • blocking or activating experiments; mouse
Villegas Mendez A, Shaw T, Inkson C, Strangward P, de Souza J, Couper K. Parasite-Specific CD4+ IFN-γ+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection. Infect Immun. 2016;84:34-46 pubmed publisher
  • flow cytometry; mouse; loading ...; fig 5c
León B, Bradley J, Lund F, Randall T, Ballesteros Tato A. FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability. Nat Commun. 2014;5:3495 pubmed publisher
Cohen T, Takahashi V, Bonnell J, Tovchigrechko A, Chaerkady R, Yu W, et al. Staphylococcus aureus drives expansion of low-density neutrophils in diabetic mice. J Clin Invest. 2019;129:2133-2144 pubmed publisher
Komai T, Inoue M, Okamura T, Morita K, Iwasaki Y, Sumitomo S, et al. Transforming Growth Factor-β and Interleukin-10 Synergistically Regulate Humoral Immunity via Modulating Metabolic Signals. Front Immunol. 2018;9:1364 pubmed publisher
Wang G, Biswas A, Ma W, Kandpal M, Coker C, Grandgenett P, et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat Med. 2018;24:770-781 pubmed publisher
Alonso R, Flament H, Lemoine S, Sedlik C, Bottasso E, Péguillet I, et al. Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node. Nat Commun. 2018;9:2113 pubmed publisher
Wang Y, Schafer C, Hough K, Tousif S, Duncan S, Kearney J, et al. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol. 2018;201:278-295 pubmed publisher
Xu M, Pokrovskii M, Ding Y, Yi R, Au C, Harrison O, et al. c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature. 2018;554:373-377 pubmed publisher
Clemente Casares X, Blanco J, Ambalavanan P, Yamanouchi J, Singha S, Fandos C, et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature. 2016;530:434-40 pubmed publisher
Manlove L, Berquam Vrieze K, Pauken K, Williams R, Jenkins M, Farrar M. Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells. J Immunol. 2015;195:4028-37 pubmed publisher
Choi Y, Gullicksrud J, Xing S, Zeng Z, Shan Q, Li F, et al. LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat Immunol. 2015;16:980-90 pubmed publisher
Bodogai M, Moritoh K, Lee Chang C, Hollander C, Sherman Baust C, Wersto R, et al. Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells. Cancer Res. 2015;75:3456-65 pubmed publisher
Greco S, Tomkötter L, Vahle A, Rokosh R, Avanzi A, Mahmood S, et al. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia. PLoS ONE. 2015;10:e0132786 pubmed publisher
Li W, Li Q, Jiao Y, Qin L, Ali R, Zhou J, et al. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest. 2014;124:755-67 pubmed publisher
Worthington J, Klementowicz J, Rahman S, Czajkowska B, Smedley C, Waldmann H, et al. Loss of the TGFβ-activating integrin αvβ8 on dendritic cells protects mice from chronic intestinal parasitic infection via control of type 2 immunity. PLoS Pathog. 2013;9:e1003675 pubmed publisher
Tai N, Wong F, Wen L. TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice. J Immunol. 2013;191:2926-37 pubmed publisher
Ring S, Maas M, Nettelbeck D, Enk A, Mahnke K. Targeting of autoantigens to DEC205? dendritic cells in vivo suppresses experimental allergic encephalomyelitis in mice. J Immunol. 2013;191:2938-47 pubmed publisher
Kurkjian C, Hollifield M, Lines J, Rogosky A, Empey K, Qureshi M, et al. Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection. Infect Immun. 2012;80:2835-46 pubmed publisher
Garidou L, Heydari S, Gossa S, McGavern D. Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection. J Virol. 2012;86:7060-71 pubmed publisher
product information
Catalog Number :
BP0057-5MG
Product Name :
InVivoPlus anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-β
Host :
Mouse
Clonality :
Monoclonal
Label/Conjugation :
No
Antigen Modification :
No
Category :
Antibody
Size :
5 mg
Regular Price :
$2,615.00
Academic Price :
1,700.00 USD
Clone Name :
13F3
Isotype :
1D11.16.8
Immunogen :
Bovine TGFβ isoform 2
Reactivity :
Bovine, Canine, Hamster, Human, Monkey, Mouse, Rat
Concentration/Amount :
Lot specific,typically between 4-11 mg/ml
Reported Applications :
in vivo TGFβ neutralization, in vitro TGFβ neutralization, Western blot
Recommended Storage Conditions :
The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
more info or order :
company information
Bio X Cell
10 Technology Dr., Suite 2B
Lebanon, NH 03784-1671
customerservice@bxcell.com
http://bxcell.com
1-866-787-3444
headquarters: USA